Search results
Medicare Part D Plans Poorly Cover Adalimumab Biosimilars
Medscape· 20 hours agoThis narrow coverage limits the cost-saving potential of these biosimilar competitors, expert said.
What to know when enrolling in Medicare after age 65 with health issues
Las Vegas Review-Journal· 8 hours agoplan has a formulary, whether it is a stand-alone plan or a Medicare Advantage plan with a...
Humana and CVS are downsizing their Medicare Advantage plans for 2025. Which insurers could benefit?
Healthcare Dive via Yahoo Finance· 10 hours agoHundreds of thousands of seniors could switch plans during next year’s open enrollment, depending on...
Enrolling in Medicare over 65 with health issues
The Salem News· 9 hours agoThe 2025 Medicare Part D plans will be released on October 1. Scott, I recommend that you and Sandy begin researching which ...
CMS Redesigns the Medicare Part D Prescription Drug Program Beginning in 2025 | JD Supra
JD Supra· 4 days agoThe Final Program Instructions reflect a newly defined standard Part D benefit design through several changes or enhancements to the Part D program beginning in 2025. Of those changes or enhancements ...
Biden's Inflation Reduction Act Unravels Medicare Part D
Forbes· 7 days agoIn May, Medicare bureaucrats released new guidance that details how they'll conduct the drug pricing...
I’m Retired and I Regret Not Taking Social Security at Age 62 — Here’s Why
GOBankingRates via Yahoo Finance· 14 hours agoWhen planning for retirement with a spouse, you may be banking on the fact that both of you will...
The average retired American faces these new Medicare changes in 2025
TheStreet.com· 2 hours agoA policy announced by the Centers for Medicare and Medicaid Services involves maximum out-of-pocket expenses for seniors. There are many concerns Americans regularly confront ...
Expensive Health Insurance Premiums By Design
Forbes· 4 days agoAfter the passage of the Inflation Reduction Act, the Medicare Part D average premium jumped 21% from 2023 to 2024 ...
LivaNova stock falls 11% on VNS Therapy study setback (NASDAQ:LIVN)
Seeking Alpha· 9 hours agoLivaNova (LIVN) stock fell 11% on news that unipolar patient cohort of RECOVER study for its VNS...